Preview

Translational Medicine

Advanced search

Pecularities of the ischemic heart disease clinical course in patients with different provision of vitamin D, residents of St. Petersburg: an association with a complex of genotypes of vitamin D receptor

https://doi.org/10.18705/2311-4495-2022-9-2-6-14

Abstract

Background. Vitamin D has been shown to reduce the risk of atherosclerosis development. Vitamin D receptors (VDRs) mediate the protective effects of vitamin D on immune inflammation in the vascular wall. Polymorphisms of the VDR gene are involved in the regulation of the stability of its mRNA. The carriage of some polymorphisms may affect the development of atherosclerosis.

Objective. To study the availability of vitamin D in patients with coronary artery disease (CAD) with various VDR polymorphisms.

Design and methods. The vitamin D level in blood serum was determined by enzyme immunoassay. The genotypes of the VDR gene were determined in 302 patients with CAD and in 196 patients without CAD by PCR.

Results. The level of vitamin D in patients with CAD was lower than in controls. The presence of the studied VDR polymorphisms was not associated with an increased risk of CAD. The content of vitamin D was higher in patients with the BB vs. bb genotype of the VDR gene (BsmI), in carriers of the AA vs. aa genotype (ApaI), in carriers of TT vs. tt genotype of the VDR gene (TaqI).

Conclusion. TaqI, FokI, ApaI and BsmI polymorphisms are not associated with the risk of CAD. Vitamin D level in the CAD patients with BB and AA genotype of the VDR gene was higher compare with bb and aa genotypes.

About the Authors

O. A. Berkovich
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Olga A. Berkovich, PhD, professor of the Faculty Therapy Department with a course of endocrinology and cardiology with a clinic, head of Ischemic Heart Disease Laboratory of Research Institute of Cardiovascular Diseases of Scientific and Clinical Research Center

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



Zh. I. Ionova
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Zhanna I. Ionova, assistant of the Faculty Therapy Department with a course of endocrinology and cardiology with a clinic

L’va Tolstogo str., 6/8, Saint Petersburg, 197022


Competing Interests:

The authors declare no conflict of interest.



S. N. Pchelina
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Sofya N. Pchelina, PhD, head of Department of Molecular Genetic and Nanobiological Technologies of Scientific and Clinical Research Center

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



J. Du
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Jin Du, PhD student at the Department of Faculty Therapy with a course in Endocrinology and Cardiology with a clinic

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



V. V. Miroshnikova
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Valentina V. Miroshnikova, PhD, head of the Laboratory of Medical Genetics of the Department of Molecular Genetic and Nanobiological Technologies of Scientific and Clinical Research Center

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



A. A. Botkina
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Arina A. Botkina, student

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



K. V. Dracheva
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Kseniya V. Dracheva, laboratory assistant of the Laboratory of Medical Genetics of the Department of Molecular Genetic and Nanobiological Technologies of Scientific and Clinical Research Center

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



O. D. Belyaeva
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Olga D. Belyaeva, PhD, professor of the Faculty Therapy Department with a course of endocrinology and cardiology with a clinic, head of Arterial Hypertension Laboratory of Research Institute of Cardiovascular Diseases of Scientific and Clinical Research Center

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest.



References

1. Ragino YuI, Kuzminykh NA, Shcherbakova LV, et al. Prevalence of coronary heart disease (by epidemiological criteria) and its association with lipid and non-lipid risk factors in the Novosibirsk population of 25–45 years. Russian Journal of Cardiology. 2019;(6):78–84. In Russian. DOI: 10.15829/1560-4071-2019-6-78-84.

2. Seferović JP, Milinković I, Tešić M, et al. The role of glycemia in acute heart failure patients. Clin Chem Lab Med. 2014; 52(10):1437–1446. DOI: 10.1515/cclm-2014-0239.

3. Tikkanen E, Havulinna AS, Palotie A, et al. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease. Arterioscler Thromb Vasc Biol. 2013; 33(9):2261–2266. DOI: 10.1161/ATVBAHA.112.301120.

4. Li A, Zhang W, Zhang H, et al. Vitamin D/ vitamin D receptor, autophagy and inflammation relevant diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017; 42(8):979–985. In Chinese. DOI: 10.11817/j.issn.1672-7347.2017.08.017.

5. Sergeeva EG, Berkovich OA, Gorbach AV, et al. Vitamin D deficiency, immune inflammation and risk of cardiovascular disease. In. Translational medicine 2nd ed. Saint-Petersburg, Almazov National Medical Research Centre, 2015:416–422. In Russian.

6. Latic N, Erben RG. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure. Int J Mol Sci. 2020; 21(18):6483. DOI: 10.3390/ijms21186483.

7. Mohammad S, Mishra A, Ashraf MZ. Emerging Role of Vitamin D and its Associated Molecules in Pathways Related to Pathogenesis of Thrombosis. Bio-molecules. 2019; 9(11):649. DOI: 10.3390/biom9110649.

8. Karonova TL, Belyaeva OD, Bystrova AA, et al. Lipids profile in vitamin D in-sufficient/deficient subjects with different genotypes of vitamin D receptor gene. Arterial’naya Gipertenziya=Arterial Hypertension. 2019; 25(5):557–567. In Russian. DOI: 10.18705/1607-419X-2019-25-5-557-567.

9. Serpil E, Sade Е, Özçalık Е, et al. Association between Vitamin D Levels and Presence, Severity of Coronary Artery Disease. PP-095JACC. 2013; 62(18):Suppl Abstracts/POSTERS C119. DOI: 10.1016/j.jacc.2013.08.362.

10. Petrushkina AA, Pigarova EA, Rozhinskaya LYa. The prevalence of vitamin D deficiency in Russian Federation. Osteoporosis and Bone Diseases. 2018; 21(3):15–20. In Russian. DOI: 10.14341/osteo10038.

11. Zdrenghea MT, Makrinioti H, Bagacean C, et al. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017; 27(1). DOI: 10.1002/rmv.1909.

12. Alizadeh S, Djafarian K, Alizadeh H, et al. Common Variants of Vitamin D Receptor Gene Polymorphisms and Susceptibility to Coronary Artery Disease: A Systematic Review and Meta-Analysis. J Nutrigenet Nutrigenomics. 2017; 10(1-2):9–18. DOI: 10.1159/000455914.

13. He L, Wang M. Association of vitamin d receptor — a gene polymorphisms with coronary heart disease in Han Chinese. Int J Clin Exp Med. 2015;8(4):6224–6229.

14. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013; 88(7):720–755. DOI: 10.1016/j.mayocp.2013.05.011.

15. Lu S, Guo S, Hu F, et al. The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016; 95(21):e3467. DOI: 10.1097/MD.0000000000003467.


Review

For citations:


Berkovich O.A., Ionova Zh.I., Pchelina S.N., Du J., Miroshnikova V.V., Botkina A.A., Dracheva K.V., Belyaeva O.D. Pecularities of the ischemic heart disease clinical course in patients with different provision of vitamin D, residents of St. Petersburg: an association with a complex of genotypes of vitamin D receptor. Translational Medicine. 2022;9(2):6-14. (In Russ.) https://doi.org/10.18705/2311-4495-2022-9-2-6-14

Views: 517


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-4495 (Print)
ISSN 2410-5155 (Online)